Results 261 to 270 of about 9,107,460 (340)

Financial reimbursement incentives in the use of biosimilars for rheumatoid arthritis in Japan. [PDF]

J Pharm Policy Pract
Mamiya H, Fukasawa T, Kawakami K.
europepmc   +1 more source

Developing a policy maturity model for prescription digital therapeutics based on expert consensus: protocol for an eDelphi study. [PDF]

BMJ Open
Rocha-Gomes J, Sousa-Pinto B, Neves AL.
europepmc   +1 more source

Valley Fever in Central California: Diagnosis is Not the Finish Line, the Real Gap is Longitudinal Care. [PDF]

Clin Infect Dis
Sivasubramanian G.
europepmc   +1 more source

Higher risk, lower reimbursement: medicare payment paradox in cranial neurosurgery. [PDF]

Neurosurg Rev
Schneider D, Brown EDL, White TG, Eichberg DG, Elsamadicy AA, Sciubba DM, Lo SL, Park J.   +7 more
europepmc   +1 more source

A study on the accessibility and utilisation of targeted drugs for pulmonary arterial hypertension in China. [PDF]

Front Pharmacol
Li W, Zhang H, Xu L, Tang W, Lu W, You Z, Wu H, Lin Y, Chen H.   +8 more
europepmc   +1 more source

Financial protection and healthcare utilization for low-income populations under China's multi-tiered health financing system: a cross-sectional study in an Eastern city. [PDF]

BMC Health Serv Res
Zhang X, Zhu K, Cui Y, Feng R.
europepmc   +1 more source

The Analysis of Firms and Employees: Quantitative and Qualitative Approaches [PDF]

Colleen Flaherty Manchester
core  

PUBLIC AND PRIVATE PROVISION OF HEALTCH CARE [PDF]

Pedro P. Barras, Xavier Martinez-Giralt
core  

[The opinion about the reimbursement mechanism for psychotropic drugs for mental disorders].

Psychiatria polska, 2004
openaire   +1 more source